- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of PALB2 as a Candidate Melanoma Susceptibility Gene
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 6, Pages e100683
Publisher
Public Library of Science (PLoS)
Online
2014-06-21
DOI
10.1371/journal.pone.0100683
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
- (2013) Ana Blanco et al. PLoS One
- Prevalence of PALB2 Mutations in Breast Cancer Patients in Multi-Ethnic Asian Population in Malaysia and Singapore
- (2013) Sze Yee Phuah et al. PLoS One
- Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families
- (2012) Irene Catucci et al. Familial Cancer
- Toward an Improved Definition of the Tumor Spectrum Associated WithBAP1Germline Mutations
- (2012) Thomas Wiesner et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel germline PALB2 truncating mutations in African American breast cancer patients
- (2011) Yonglan Zheng et al. CANCER
- Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
- (2011) S. Casadei et al. CANCER RESEARCH
- Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer
- (2011) Xiaohong R. Yang et al. Familial Cancer
- PALB2 mutations in familial breast and pancreatic cancer
- (2011) Erin W. Hofstatter et al. Familial Cancer
- Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
- (2011) A. Moran et al. Familial Cancer
- Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer
- (2011) Heide Hellebrand et al. HUMAN MUTATION
- Germline PALB2 mutation analysis in breast-pancreas cancer families
- (2011) Z. K. Stadler et al. JOURNAL OF MEDICAL GENETICS
- A novel germline PALB2 deletion in Polish breast and ovarian cancer patients
- (2010) Agnieszka Dansonka-Mieszkowska et al. BMC Medical Genetics
- PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer
- (2010) Paolo Peterlongo et al. BREAST CANCER RESEARCH AND TREATMENT
- PALB2 mutations in European familial pancreatic cancer families
- (2010) EP Slater et al. CLINICAL GENETICS
- Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma
- (2010) N. Sabbaghian et al. Familial Cancer
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- The contribution of founder mutations to early-onset breast cancer in French-Canadian women
- (2009) P Ghadirian et al. CLINICAL GENETICS
- A PALB2 germline mutation associated with hereditary breast cancer in Italy
- (2009) Laura Papi et al. Familial Cancer
- PALB2 sequence variants in young South African breast cancer patients
- (2009) Michelle Sluiter et al. Familial Cancer
- Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic Cancer
- (2009) Marc D. Tischkowitz et al. GASTROENTEROLOGY
- Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
- (2009) S. Jones et al. SCIENCE
- The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
- (2008) A-Yong Cao et al. BREAST CANCER RESEARCH AND TREATMENT
- Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families
- (2008) María J. García et al. BREAST CANCER RESEARCH AND TREATMENT
- Analysis of the gene coding for the BRCA2-Interacting protein PALB2 in hereditary prostate cancer
- (2008) Marc Tischkowitz et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started